Thuy T Le Selected Research

Pharmaceutical Preparations

5/2022	Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction.
6/2014	CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritis.
1/2013	Effective treatment of squamous cell carcinomas with ingenol mebutate gel in immunologically intact SKH1 mice.
3/2011	A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thuy T Le Research Topics

Disease

11	Infections 05/2021 - 08/2010
7	Arthritis (Polyarthritis) 01/2018 - 08/2010
5	Inflammation (Inflammations) 01/2021 - 01/2013
4	COVID-19 02/2022 - 01/2021
3	Neoplasms (Cancer) 05/2022 - 06/2014
3	Edema (Dropsy) 01/2019 - 09/2012
3	Actinic Keratosis 01/2017 - 01/2013
2	Infectious Arthritis (Septic Arthritis) 02/2022 - 06/2014
2	Weight Loss (Weight Reduction) 02/2022 - 07/2020
2	Vaccinia 01/2021 - 01/2018
2	Viremia 01/2018 - 08/2010
2	Fever (Fevers) 12/2017 - 09/2012
2	Chikungunya Fever 01/2017 - 12/2014
2	Fibrosis (Cirrhosis) 01/2016 - 02/2012
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2016 - 02/2012
1	Bites and Stings (Sting) 01/2021
1	Thrombosis (Thrombus) 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Cicatrix (Scar) 01/2017
1	Chronic Disease (Chronic Diseases) 01/2017
1	Joint Diseases (Joint Disease) 01/2017
1	Experimental Melanoma 01/2016
1	Hypoxia (Hypoxemia) 01/2016
1	Contact Dermatitis (Eczema, Contact) 01/2016
1	Skin Neoplasms (Skin Cancer) 01/2016
1	Idiopathic Pulmonary Fibrosis 01/2016
1	Pneumonia (Pneumonitis) 09/2014
1	Pulmonary Edema 09/2014
1	Lung Injury 09/2014
1	Hyperoxia 09/2014
1	Necrosis 01/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2013
1	Oliguria 09/2012
1	Shock 09/2012
1	Thrombocytopenia (Thrombopenia) 09/2012
1	Hypothermia 09/2012
1	Hemorrhage 09/2012
1	Vasculitis (Vasculitides) 09/2012
1	Arthralgia (Joint Pain) 03/2011
1	Rheumatic Diseases (Rheumatism) 08/2010
1	Head and Neck Neoplasms (Head and Neck Cancer) 02/2009
1	Infectious Mononucleosis (Glandular Fever) 02/2008
1	Injection Site Reaction 02/2008
1	Coronary Disease (Coronary Heart Disease) 03/2003

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 01/2021 - 02/2008
5	RNA (Ribonucleic Acid)IBA 02/2022 - 12/2014
4	Pharmaceutical PreparationsIBA 05/2022 - 03/2011
3	Neutralizing AntibodiesIBA 07/2020 - 01/2013
3	3-ingenyl angelateIBA 01/2017 - 01/2013
2	Drinking WaterIBA 02/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 02/2022 - 05/2021
2	Granzymes (Granzyme)IBA 01/2019 - 01/2017
2	Interferon Type IIBA 01/2019 - 12/2017
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2016 - 02/2012
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2016 - 06/2014
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2016 - 06/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2012 - 08/2010
1	SARS-CoV-2 spike proteinIBA 05/2022
1	Polystyrenes (Polystyrene)IBA 02/2022
1	MicroplasticsIBA 02/2022
1	NanovaccinesIBA 10/2021
1	Karyopherins (Importin)IBA 05/2021
1	InflammasomesIBA 01/2021
1	Volatile Fatty AcidsIBA 01/2019
1	Hemostatics (Antihemorrhagics)IBA 01/2019
1	Butyrates (Butyrate)IBA 01/2019
1	Proteinase-Activated ReceptorsIBA 01/2019
1	CollagenIBA 01/2016
1	DinitrofluorobenzeneIBA 01/2016
1	Interleukin-1 (Interleukin 1)IBA 01/2016
1	Phorbol EstersIBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	CytokinesIBA 01/2016
1	AntigensIBA 12/2014
1	Immunologic Factors (Immunomodulators)IBA 12/2014
1	Oxygen (Dioxygen)IBA 09/2014
1	OccludinIBA 09/2014
1	Adenosine (Adenocard)FDA LinkGeneric 09/2014
1	Chemokine ReceptorsIBA 06/2014
1	Plasminogen InactivatorsIBA 06/2014
1	CCR2 ReceptorsIBA 06/2014
1	InterferonsIBA 09/2012
1	Interferon-betaIBA 09/2012
1	osteoblast cadherinIBA 02/2012
1	Monoclonal AntibodiesIBA 02/2012
1	Adenovirus VaccinesIBA 03/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 08/2010
1	AntibodiesIBA 08/2010
1	Interferon-gamma (Interferon, gamma)IBA 08/2010
1	HLA-B Antigens (HLA-B)IBA 02/2008
1	Peptides (Polypeptides)IBA 02/2008
1	EpitopesIBA 02/2008
1	CalciumIBA 03/2003

Therapy/Procedure

2	Therapeutics 01/2017 - 08/2010
1	Intramuscular Injections 01/2021
1	Subcutaneous Injections 01/2019
1	Aftercare (After-Treatment) 01/2017
1	Re-Irradiation 02/2009